Navigating Opiate Use Disorder Treatment Amid COVID-19 with Dr. Laura Kehoe
The medications that we use to treat this illness, by definition, are not one addiction for another, are not trading an addiction for another, because they don't cause the euphoria, they don't cause the chasing of the drug or the behavioral manifestations of active addiction.
The COVID-19 pandemic has thrown a wrench into many aspects of healthcare, but treating opiate use disorders has faced unique challenges. In this episode of 'The Right Mind Media Podcast', hosts Jon Cohan and Gabrielle Dean sit down with Dr. Laura Kehoe to dissect these hurdles and uncover some surprising silver linings. From reduced accessibility and increased screening processes to staff shortages, the landscape of addiction treatment has been dramatically altered. Yet, it's not all bleak. Dr.
Kehoe highlights the rise of virtual care and expanded harm reduction efforts as unexpected positives during these trying times. She stresses the importance of personalized care and the effectiveness of medications like extended-release injectable buprenorphine and methadone, which help manage opiate use disorders without causing euphoria or other addictive behaviors. For those feeling lost or disconnected from care, programs like the Bridge Clinic offer immediate-access addiction treatment, ensuring no one is left behind. Dr.
Kehoe's dedication to treating every individual with compassion and tailored care shines through, making this episode a beacon of hope for anyone grappling with opiate use disorder. Whether you're directly affected or supporting someone who is, this conversation offers valuable insights and practical solutions. Tune in to learn more about how treatment options have adapted and why there's still hope in these challenging times.